FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40124911000001100: Koselugo 25mg capsules (AstraZeneca UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2054091000001112 Koselugo 25mg capsules (AstraZeneca UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2054101000001118 Koselugo 25mg capsules (AstraZeneca UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Koselugo 25mg capsules (AstraZeneca UK Ltd) Is a Selumetinib 25mg capsules true Inferred relationship Existential restriction modifier
Koselugo 25mg capsules (AstraZeneca UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Koselugo 25mg capsules (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Koselugo 25mg capsules (AstraZeneca UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Koselugo 25mg capsules (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Koselugo 25mg capsules (AstraZeneca UK Ltd) Is a Koselugo true Inferred relationship Existential restriction modifier
Koselugo 25mg capsules (AstraZeneca UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Koselugo 25mg capsules (AstraZeneca UK Ltd) Has specific active ingredient Selumetinib hydrogen sulfate true Inferred relationship Existential restriction modifier
Koselugo 25mg capsules (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Koselugo 25mg capsules (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Selumetinib true Inferred relationship Existential restriction modifier
Koselugo 25mg capsules (AstraZeneca UK Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Koselugo 25mg capsules (AstraZeneca UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Koselugo 25mg capsules (AstraZeneca UK Ltd) 60 capsule Has AMP True Koselugo 25mg capsules (AstraZeneca UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start